Key Details
Price
$7.71Annual ROE
-1130.31%Beta
2.55Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
May 16, 2022Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Dec 4, 2024Analyst ratings
Recent major analysts updates
Feb 7, 25 HC Wainwright & Co.
BuyFeb 6, 25 HC Wainwright & Co.
BuyDec 18, 24 HC Wainwright & Co.
BuyNov 15, 24 HC Wainwright & Co.
BuyOct 24, 24 HC Wainwright & Co.
BuySep 6, 24 HC Wainwright & Co.
BuyAug 15, 24 HC Wainwright & Co.
BuyMay 29, 24 HC Wainwright & Co.
BuyMay 16, 24 HC Wainwright & Co.
BuyApr 16, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
TransCode Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for TransCode Therapeutics?
- Does TransCode Therapeutics pay dividends?
- What sector is TransCode Therapeutics in?
- What industry is TransCode Therapeutics in?
- What country is TransCode Therapeutics based in?
- When did TransCode Therapeutics go public?
- Is TransCode Therapeutics in the S&P 500?
- Is TransCode Therapeutics in the NASDAQ 100?
- Is TransCode Therapeutics in the Dow Jones?
- When was TransCode Therapeutics's last earnings report?
- When does TransCode Therapeutics report earnings?
- Should I buy TransCode Therapeutics stock now?
What is the ticker symbol for TransCode Therapeutics?
The ticker symbol for TransCode Therapeutics is NASDAQ:RNAZ
Does TransCode Therapeutics pay dividends?
No, TransCode Therapeutics does not pay dividends
What sector is TransCode Therapeutics in?
TransCode Therapeutics is in the Healthcare sector
What industry is TransCode Therapeutics in?
TransCode Therapeutics is in the Biotechnology industry
What country is TransCode Therapeutics based in?
TransCode Therapeutics is headquartered in United States
When did TransCode Therapeutics go public?
TransCode Therapeutics's initial public offering (IPO) was on July 8, 2021
Is TransCode Therapeutics in the S&P 500?
No, TransCode Therapeutics is not included in the S&P 500 index
Is TransCode Therapeutics in the NASDAQ 100?
No, TransCode Therapeutics is not included in the NASDAQ 100 index
Is TransCode Therapeutics in the Dow Jones?
No, TransCode Therapeutics is not included in the Dow Jones index
When was TransCode Therapeutics's last earnings report?
TransCode Therapeutics's most recent earnings report was on May 16, 2022
When does TransCode Therapeutics report earnings?
The date for TransCode Therapeutics's next earnings report has not been announced yet
Should I buy TransCode Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions